MSB 12.1% 55.5¢ mesoblast limited

Cell Therapy News/Articles, page-9

  1. 6,075 Posts.
    lightbulb Created with Sketch. 1021
    Because Mesoblast is a global leader in cell therapy and research. Any activity in this space and progress especially commentary out of the fda and approvals in this space must be considered when looking at the progress of the overall sector of regenerative medicine.

    To ignore the activity and commentary in this space for its therapeudic benefits wouldn't be prudent.


    I remain positive on this sector and on Mesoblast's leading involvement in this space.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
7 99223 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 44000 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 28/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.